Showing results (1-10 of 157) with videos related to
Sort By:
Pageof 16
Journal of Medicinal Chemistry|November 2, 2023
Exploring Fatty Acid Mimetics as NR4A LigandsTanja Stiller, Daniel MerkRSC Medicinal Chemistry|August 18, 2025
Fragment-based discovery of dual ligand pharmacophores for lipid-sensing transcription factors for designed polypharmacologyTanja Stiller, Silke Duensing-Kropp, Julian A Marschner, et al.Journal of Medicinal Chemistry|May 31, 2023
<i>De Novo</i> Design of Nurr1 Agonists <i>via</i> Fragment-Augmented Generative Deep Learning in Low-Data RegimeMarco Ballarotto, Sabine Willems, Tanja Stiller, et al.Journal of Medicinal Chemistry|January 26, 2026
Structural Tuning of Vidofludimus for High-Efficacy NR4A AgonismJan Vietor, Romy Busch, Úrsula López-García, et al.Chemmedchem|June 14, 2026
Development of a Brain-Penetrant Nurr1 Agonist ToolJan Vietor, Tanja Stiller, Christian Gege, et al.ACS Pharmacology & Translational Science|March 20, 2025
Fatty Acid Mimetic Fragments as Liver Receptor Homologue-1 ModulatorsAlisa Lang, Tanja Stiller, Niklas Ildefeld, et al.Journal of Medicinal Chemistry|July 17, 2025
Carboxylic Acid Bioisosteres Boost Nurr1 Agonist SelectivityTanja Stiller, Christian Gege, Wael Saeb, et al.Journal of Medicinal Chemistry|May 1, 2023
Development of a Potent Nurr1 Agonist Tool for In Vivo ApplicationsJan Vietor, Christian Gege, Tanja Stiller, et al.Expert Opinion on Therapeutic Patents|June 7, 2025
Nurr1 modulators - a patent review (2019-present)Markus Egner, Daniel MerkMethods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Development of Nuclear Receptor ModulatorsSimone Schierle, Daniel MerkPageof 16